Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

6825 ARTÍCULOS , VIENDO DEL 2161 AL 2175

Alzheimer's Disease Patients in the Crosshairs of COVID-19

Perry G.

J Alzheimers Dis. 2020;76(1):1. doi: 10.3233/JAD-209004.

Cerebrospinal Fluid Amyloid Beta, Tau Levels, Apolipoprotein, and (1)H-MRS Brain Metabolites in Alzheimer's Disease: A Systematic Review

Piersson AD, Mohamad M, Rajab F, Suppiah S.

Acad Radiol. 2021 Oct;28(10):1447-1463. doi: 10.1016/j.acra.2020.06.006. Epub 2020 Jul 7.

Meta-analysis of Ginkgo biloba Preparation for the Treatment of Alzheimer's Disease

Liao Z, Cheng L, Li X, Zhang M, Wang S, Huo R.

Clin Neuropharmacol. 2020 Jul/Aug;43(4):93-99. doi: 10.1097/WNF.0000000000000394.

Calcium Channel Blockers: A Possible Potential Therapeutic Strategy for the Treatment of Alzheimer's Dementia Patients with SARS-CoV-2 Infection

Danta CC.

ACS Chem Neurosci. 2020 Aug 5;11(15):2145-2148. doi: 10.1021/acschemneuro.0c00391. Epub 2020 Jul 14.

Education Research: Online Alzheimer education for high school and college students: A randomized controlled trial

Saif N, Niotis K, Dominguez M, Hodes JF, Woodbury M, Amini Y, Sadek G, Scheyer O, Caesar E, Hristov H, Knowlton N, Lee P, McInnis M, Isaacson RS.

Neurology. 2020 Oct 20;95(16):e2305-e2313. doi: 10.1212/WNL.0000000000009859. Epub 2020 Jul 14.

Primary Age-Related Tauopathy (PART): Addressing the Spectrum of Neuronal Tauopathic Changes in the Aging Brain

Hickman RA, Flowers XE, Wisniewski T.

Curr Neurol Neurosci Rep. 2020 Jul 14;20(9):39. doi: 10.1007/s11910-020-01063-1.

Quinones as preventive agents in Alzheimer's diseases: focus on NLRP3 inflammasomes

Chen DB, Gao HW, Peng C, Pei SQ, Dai AR, Yu XT, Zhou P, Wang Y, Cai B.

J Pharm Pharmacol. 2020 Nov;72(11):1481-1490. doi: 10.1111/jphp.13332. Epub 2020 Jul 15.

Effect of Rotigotine vs Placebo on Cognitive Functions Among Patients With Mild to Moderate Alzheimer Disease: A Randomized Clinical Trial

Koch G, Motta C, Bonnì S, Pellicciari MC, Picazio S, Casula EP, Maiella M, Di Lorenzo F, Ponzo V, Ferrari C, Scaricamazza E, Caltagirone C, Martorana A.

JAMA Netw Open. 2020 Jul 1;3(7):e2010372. doi: 10.1001/jamanetworkopen.2020.10372.

Could Self-Consciousness Be Enhanced in Alzheimer's Disease? An Approach from Emotional Sensorial Stimulation

Arroyo-Anlló EM, Sánchez JC, Gil R.

J Alzheimers Dis. 2020;77(2):505-521. doi: 10.3233/JAD-200408.

Alzheimer's Disease and its Related Dementias among Asian Americans, Native Hawaiians, and Pacific Islanders: A Scoping Review

Lim S, Mohaimin S, Min D, Roberts T, Sohn YJ, Wong J, Sivanesathurai R, Kwon SC, Trinh-Shevrin C.

J Alzheimers Dis. 2020;77(2):523-537. doi: 10.3233/JAD-200509.

A systematic review of the prevalence of depression, anxiety, and apathy in frontotemporal dementia, atypical and young-onset Alzheimer's disease, and inherited dementia

Collins JD, Henley SMD, Suárez-González A.

Int Psychogeriatr. 2023 Sep;35(9):457-476. doi: 10.1017/S1041610220001118. Epub 2020 Jul 20.

Brain delivery of supplemental docosahexaenoic acid (DHA): A randomized placebo-controlled clinical trial

Arellanes IC, Choe N, Solomon V, He X, Kavin B, Martinez AE, Kono N, Buennagel DP, Hazra N, Kim G, D'Orazio LM, McCleary C, Sagare A, Zlokovic BV, Hodis HN, Mack WJ, Chui HC, Harrington MG, Braskie MN, Schneider LS, Yassine HN.

EBioMedicine. 2020 Sep;59:102883. doi: 10.1016/j.ebiom.2020.102883. Epub 2020 Jul 17.

Safety and target engagement profile of two oxaloacetate doses in Alzheimer's patients

Vidoni ED, Choi IY, Lee P, Reed G, Zhang N, Pleen J, Mahnken JD, Clutton J, Becker A, Sherry E, Bothwell R, Anderson H, Harris RA, Brooks W, Wilkins HM, Mosconi L, Burns JM, Swerdlow RH.

Alzheimers Dement. 2021 Jan;17(1):7-17. doi: 10.1002/alz.12156. Epub 2020 Jul 27.

Christin Nance, B.A, and Sarah Banks, Ph.D., recipients of the 2019 Alzheimer Award

J Alzheimers Dis. 2020;76(2):443-444. doi: 10.3233/JAD-209005.

Health Outcome Prioritization in Alzheimer's Disease: Understanding the Ethical Landscape

McKeown A, Turner A, Angehrn Z, Gove D, Ly A, Nordon C, Nelson M, Tochel C, Mittelstadt B, Keenan A, Smith M, Singh I.

J Alzheimers Dis. 2020;77(1):339-353. doi: 10.3233/JAD-191300.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias